We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

261 hedge funds and large institutions have $2.14B invested in Myriad Genetics in 2013 Q2 according to their latest regulatory filings, with 261 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

59% less call options, than puts

Call options by funds: $42.7M | Put options by funds: $104M

Holders
261
Holders Change
+261
Holders Change %
–
% of All Funds
8.52%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
261
Increased
–
Reduced
–
Closed
–
Calls
$42.7M
Puts
$104M
Net Calls
-$61.7M
Net Calls Change
-$61.7M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
1
Royce & Associates
New York
$289M +$311M +10,744,395 New
MNA
2
Manning & Napier Advisors
New York
$155M +$167M +5,764,067 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$118M +$128M +4,400,097 New
Capital Research Global Investors
4
Capital Research Global Investors
California
$72.6M +$78.3M +2,700,900 New
Renaissance Technologies
5
Renaissance Technologies
New York
$61.2M +$66.1M +2,279,374 New
SCM
6
Sterling Capital Management
North Carolina
$56.8M +$61.2M +2,112,359 New
BIT
7
BlackRock Institutional Trust
California
$56.2M +$60.6M +2,090,221 New
SFM
8
Systematic Financial Management
New Jersey
$55.1M +$59.4M +2,050,089 New
Goldman Sachs
9
Goldman Sachs
New York
$48.5M +$52.3M +1,805,785 New
State Street
10
State Street
Massachusetts
$48.1M +$51.9M +1,788,992 New
TAM
11
Tiverton Asset Management
Delaware
$47.8M +$51.6M +1,780,200 New
BA
12
BlackRock Advisors
Delaware
$43.4M +$46.9M +1,616,543 New
BTW
13
Boston Trust Walden
Massachusetts
$35M +$37.7M +1,300,947 New
BFA
14
BlackRock Fund Advisors
California
$34.2M +$36.9M +1,274,183 New
PA
15
Pinnacle Associates
New York
$34.1M +$36.8M +1,268,856 New
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$31.8M +$34.3M +1,185,101 New
Fidelity Investments
17
Fidelity Investments
Massachusetts
$27.5M +$29.7M +1,023,298 New
CM
18
CS McKee
Pennsylvania
$25.7M +$27.8M +957,830 New
WA
19
Wasatch Advisors
Utah
$24.1M +$26M +897,369 New
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$23.5M +$25.4M +875,624 New
First Trust Advisors
21
First Trust Advisors
Illinois
$23.1M +$24.9M +858,374 New
PCMI
22
Paradigm Capital Management Inc
New York
$22.4M +$24.1M +833,073 New
NAP
23
New Amsterdam Partners
New York
$21.8M +$23.6M +812,656 New
DGI
24
Disciplined Growth Investors
Minnesota
$20.8M +$22.4M +774,520 New
SGAM
25
Smith Group Asset Management
Texas
$20.4M +$22M +759,039 New
1
2 3 4 5

MYGN Hedge Fund Activity: Q2 2013 in Review

261 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q2 2013, worth a combined $2.14B.

Buyers outnumbered sellers: 261 funds opened new MYGN positions and 0 closed out — a net gain of 261 holders — while 0 added to existing stakes and 0 trimmed.

  • 261 institutional investors held Myriad Genetics (MYGN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $2.14B of Myriad Genetics stock for Q2 2013.
  • 261 funds opened new Myriad Genetics positions in Q2 2013 and 0 closed out, a net change of +261 holders.

Based on aggregated 13F filings for Q2 2013.